Screener
OrthoPediatrics KIDS Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by OrthoPediatrics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: OrthoPediatrics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 1:56 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001425450-26-000070
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Payment on debt issuance costs | (289) | — |
| Payments on mortgage notes | (85) | (78) |
| Payments on acquisition notes | (977) | (248) |
| Net cash (used in) provided by financing activities | (1,351) | 24,674 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (68) | 304 |
| NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | (2,565) | 828 |
| Cash, cash equivalents and restricted cash, beginning of year | $21,620 | $45,777 |
| Cash, cash equivalents and restricted cash, end of period | $19,055 | $46,605 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is OrthoPediatrics's financing cash flow?
- OrthoPediatrics (KIDS) reported financing cash flow of -$737K in Q2 2026.
- How has OrthoPediatrics's financing cash flow changed year-over-year?
- OrthoPediatrics's financing cash flow decreased by 103.0% year-over-year, from $24.8M to -$737K.
- What is the long-term trend for OrthoPediatrics's financing cash flow?
- Over 2 years (2022 to 2024), OrthoPediatrics's financing cash flow has grown at a -37.2% compound annual growth rate (CAGR), from $136.01M to $53.68M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about OrthoPediatrics's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude